Physiomics Plc (LON:PYC – Get Free Report) rose 21.3% on Wednesday . The stock traded as high as GBX 1.19 ($0.01) and last traded at GBX 1 ($0.01). Approximately 5,343,470 shares traded hands during mid-day trading, a decline of 23% from the average daily volume of 6,964,461 shares. The stock had previously closed at GBX 0.83 ($0.01).
Physiomics Stock Performance
The company has a market cap of £2.40 million, a PE ratio of -13.83 and a beta of 1.69. The firm’s 50 day moving average is GBX 0.75 and its 200-day moving average is GBX 0.71.
Insider Buying and Selling
In other Physiomics news, insider Peter Sargent purchased 459,090 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was purchased at an average price of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,670.58). 4.18% of the stock is owned by corporate insiders.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Read More
- Five stocks we like better than Physiomics
- The Risks of Owning Bonds
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
